Cardiometabolic trials: Using expertise to turn complexity into robust results

April 24, 2026

Pharmaceutical Technology

Discover how Nucleus Network Minneapolis delivers reliable Phase 1-2a cardiometabolic trials with AI-driven recruitment, high retention, rigorous PI oversight, and advanced imaging for decision-grade